0001225208-22-003724.txt : 20220301
0001225208-22-003724.hdr.sgml : 20220301
20220301175532
ACCESSION NUMBER: 0001225208-22-003724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SUSMAN SALLY
CENTRAL INDEX KEY: 0001263544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 22700100
MAIL ADDRESS:
STREET 1: 767 FIFTH AVE
STREET 2: EOTIC LAWDER CORP
CITY: NEW YORK
STATE: NY
ZIP: 10153
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2022-02-26
0000078003
PFIZER INC
PFE
0001263544
SUSMAN SALLY
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Executive Vice President
Common Stock
2022-02-26
4
M
0
63580.0000
25.6000
A
172880.0000
D
Common Stock
2022-02-26
4
F
0
18745.0000
47.7200
D
154135.0000
D
Common Stock
2022-02-26
4
F
0
29685.0000
50.6400
D
124450.0000
D
Common Stock
747.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
25.6000
2022-02-26
4
M
0
63580.0000
0.0000
D
2022-02-26
2022-02-26
Common Stock
63580.0000
0.0000
D
Phantom Stock Units
2022-02-28
4
A
0
58623.0000
0.0000
A
Common Stock
58623.0000
80225.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Price is the closing price of Pfizer common stock on February 25, 2022.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Each unit represents one phantom share of common stock.
The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Susan E. Grant, by power of atty., for Sally Susman
2022-03-01